Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
- 1 May 2006
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 125 (4), 665-677
- https://doi.org/10.1016/j.cell.2006.03.041
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Ubiquitin charging of human class III ubiquitin-conjugating enzymes triggers their nuclear importThe Journal of cell biology, 2004
- Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGHLaboratory Investigation, 2004
- Toll-Like Receptor Expression in Human Keratinocytes: Nuclear Factor κB Controlled Gene Activation by Staphylococcus aureus is Toll-Like Receptor 2 But Not Toll-Like Receptor 4 or Platelet Activating Factor Receptor DependentJournal of Investigative Dermatology, 2003
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- NF-κB-inducible BCL-3 Expression Is an Autoregulatory Loop Controlling Nuclear p50/NF-κB1 ResidencePublished by Elsevier BV ,2001
- NF-κB and cell-cycle regulation: the cyclin connectionCytokine & Growth Factor Reviews, 2001
- Increased expression of p50-NF-κB and constitutive activation of NF-κB transcription factors during mouse skin carcinogenesisOncogene, 1999
- Analysis of cultured keratinocytes from a transgenic mouse model of psoriasis: effects of suprabasal integrin expression on keratinocyte adhesion, proliferation and terminal differentiationExperimental Dermatology, 1999
- Dermal eccrine cylindromatosis.Journal of Medical Genetics, 1994
- The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimersCell, 1993